Editas Medicine Inc. (formerly known as Gengine Inc.) was founded in 2013 and is based in Cambridge, Massachusetts. It is focused on the development of a genome-editing platform, targeting genetically defined diseases without an existing approved solution. The company’s process is based on a unique technology... Show More
📉 WHY EDITAS MEDICINE SELLOFF LOOKS OVERDONE?
🔸 What Happened to the stock?
The shares of Editas Medicine dropped more than 15% last Friday, after Goldman Sachs initiated coverage on $EDIT (Editas Medicine Inc) stock with a “Sell” rating and a $20 price target. At the time, the stock price was around... Show More